Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Is Slipping Today

TheMotleyFool

0 0

Shares of Moderna (NASDAQ: MRNA) were sliding 5.1% lower as of 11 a.m. ET on Tuesday. The decline appears to be the result of some profit-taking after Moderna's shares jumped on Monday after the company's CEO, Stéphane Bancel, said during an interview on CNBC that Moderna will soon begin clinical trials for a version of its COVID-19 vaccine that specifically targets the coronavirus omicron variant.

It's really not all that surprising that Moderna's bounce didn't last long. There's a good argument to be made that the vaccine stock rose more than was warranted on Monday.

Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share